4//SEC Filing
ProPhase Labs, Inc. 4
Accession 0001493152-15-005937
$PRPHCIK 0000868278operating
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 8:24 PM ET
Size
7.6 KB
Accession
0001493152-15-005937
Insider Transaction Report
Form 4
Leventhal Mark S
10% Owner
Transactions
- Award
Common Stock, par value $0.0005
2015-11-27$1.55/sh+13,300$20,615→ 881,032 total - Award
Common Stock, par value $0.0005
2015-11-30$1.48/sh+948$1,403→ 881,980 total
Holdings
- (indirect: By Foundation)
Common Stock, par value $0.0005
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.50 to $1.56, inclusive.
- [F2]These shares were purchased in a single transaction at a price of $1.48.
- [F3]The reporting person and his wife control the Mark S & Donna R Leventhal Family Foundation Inc., a charitable foundation. The reporting person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.
Documents
Issuer
ProPhase Labs, Inc.
CIK 0000868278
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000868278
Filing Metadata
- Form type
- 4
- Filed
- Nov 29, 7:00 PM ET
- Accepted
- Nov 30, 8:24 PM ET
- Size
- 7.6 KB